Effective inhibition of EGFR signalling in NSCLC cells leads to a dramatic decrease in the levels of hexokinase II and phosphopyruvate kinase M2 as well as upregulation of the mitochondrial complex subunit [193]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.